To include your compound in the COVID-19 Resource Center, submit it here.

Myrexis cancer news

Myrexis also said that NASDAQ initiated proceedings to delist the company due to its belief that Myrexis is a "public shell" and the resignation of all the

Read the full 272 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE